Tolerability and Effectiveness of Exenatide Once Weekly Relative to Basal Insulin Among Type 2 Diabetes Patients of Different Races in Routine Care.

Nunes, Anthony P; Loughlin, Anita M; Qiao, Qing; Ezzy, Stephen M; Yochum, Laura; Clifford, C Robin; Gately, Robert V; Dore, David D; Seeger, John D

Nunes, Anthony P; Loughlin, Anita M; Qiao, Qing; Ezzy, Stephen M; Yochum, Laura; Clifford, C Robin; Gately, Robert V; Dore, David D; Seeger, John D.

Afiliación

Nunes AP; Optum Epidemiology, Boston, MA, USA. anthony.nunes@optum.com.
Loughlin AM; Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA. anthony.nunes@optum.com.
Qiao Q; Optum Epidemiology, Boston, MA, USA.
Ezzy SM; Astra Zeneca, Gothenburg, Sweden.
Yochum L; Optum Epidemiology, Boston, MA, USA.
Clifford CR; Optum Epidemiology, Boston, MA, USA.
Gately RV; Optum Epidemiology, Boston, MA, USA.
Dore DD; Optum Epidemiology, Boston, MA, USA.
Seeger JD; Optum Epidemiology, Boston, MA, USA.

Diabetes Ther ; 8(6): 1349-1364, 2017 Dec.

Article en En | MEDLINE | ID: mdl-28983857

Palabras clave

Basal insulin; Effectiveness; Electronic health record; Electronic medical record; Epidemiology; Exenatide; Tolerability

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diabetes Ther Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google